The AHA yesterday urged leaders from the nation's five largest private health insurance companies — Aetna, Anthem, Humana, Cigna and UnitedHealthCare — and organizations that represent insurers (America’s Health Insurance Plans and Blue Cross Blue Shield Association) to join hospitals and health systems to "meet the historic challenge" caused by COVID-19 to "ensure that the health care system is there for anyone who needs care."

Specifically, AHA asked private insurers to:

  • support stable cash flow by allowing providers to opt into periodic interim payments and/or accelerated payments for the duration of the public health emergency, much like what is available through the Medicare program;
  • eliminate administrative processes that cause delays in payment, such as prior authorization and certain payment edits;
  • provide adequate coverage and reimbursement of services in hospitals and alternative sites of care, including by covering cost-sharing for COVID-19 treatment; and
  • expedite processing of outstanding claims that have resulted in billions of dollars in accounts receivables.

Related News Articles

Headline
Flu cases are growing or likely growing in 39 states, according to the latest Centers for Disease Control and Prevention data from Nov. 11. COVID-19…
Headline
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled…
Headline
A study published Oct. 30 by the American Heart Association found that people have an elevated risk of heart attack and stroke following flu and COVID-19…
Headline
The Centers for Disease Control and Prevention will update its immunization schedules for the COVID-19 and chickenpox vaccines to adopt recent recommendations…
Headline
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…